Complex Mutations in the Epidermal Growth Factor Receptor Gene in Non-small Cell Lung Cancer-Reference-Cited by-同舟云学术

Complex Mutations in the Epidermal Growth Factor Receptor Gene in Non-small Cell Lung Cancer

Published:2010-10 Issue:10 Volume:5 Page:1524-1528
ISSN:1556-0864
Container-title:Journal of Thoracic Oncology
language:en
Short-container-title:Journal of Thoracic Oncology

Author:

Hata Akito,Yoshioka Hiroshige,Fujita Shiro,Kunimasa Kei,Kaji Reiko,Imai Yukihiro,Tomii Keisuke,Iwasaku Masahiro,Nishiyama Akihiro,Ishida Tadashi,Katakami Nobuyuki

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine,Oncology

Reference26 articles.

1. Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib;Lynch;N Engl J Med,2004

2. EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy;Paez;Science,2004

3. Exon 19 deletion mutations of epidermal growth factor receptor are associated with prolonged survival in non-small cell lung cancer patients treated with gefitinib or erlotinib;Jackman;Clin Cancer Res,2006

4. Pooled analysis of the prospective trials of gefitinib monotherapy for EGFR-mutant non-small cell lung cancers;Costa;Lung Cancer,2007

5. Complex mutation patterns of epidermal growth factor receptor gene associated with variable responses to gefitinib treatment in patients with non-small cell lung cancer;Hsieh;Lung Cancer,2006

Cited by 77 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. TKI type switching overcomes ROS1 L2086F in ROS1 fusion-positive cancers;npj Precision Oncology;2024-08-08

2. Clinicopathological and prognostic implications of EGFR mutations subtypes in Moroccan non-small cell lung cancer patients: A first report;PLOS ONE;2024-06-05

3. An epidermal growth factor receptor compound mutation of L858R with S768I in advanced non-small-cell lung cancer: a case report;Journal of Medical Case Reports;2024-03-18

4. Clinical phase II trial shows that combining osimertinib and afatinib resistance EGFR recurrent mutation in EGFR-mutant lung cancer;Southeast Asian Journal of Health Professional;2024-03-15

5. The difference between dacomitinib and afatinib in effectiveness and safety in first-line treatment of patients with advanced EGFR-mutant non-small cell lung cancer: a real-world observational study;BMC Cancer;2024-02-19